Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Terminated 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Low-Grade Intraepithelial Neoplasia of Cervix 1Esophageal Neoplasms 1Deglutition Disorders 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × epigallocatechin gallate × Clear all
NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Shandong Cancer Hospital and Institute

Phase 2 Unknown
72 enrolled
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

NCT06314113 2024-03-15

EGCG-HPV

University of Palermo

Unknown
50 enrolled

Low-Grade Intraepithelial Neoplasia of Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡